Latest Breaking News On - Pancreas transplant program at montefiore medical center - Page 1 : comparemela.com

Press release content from PR Newswire. The AP news staff was not involved in its creation. Eurofins Transplant Diagnostics Group Receives New York State CLEP Approval for Novel Rejection Biomarker Assays April 27, 2021 GMT Eurofins Transplant Diagnostics LEE’S SUMMIT, Mo. and FRAMINGHAM, Mass., April 27, 2021 /PRNewswire/ Eurofins Viracor, one of the largest and most recognized infectious diseases testing laboratories in the United States, and Transplant Genomics, the trusted global partner in precision biomarkers for the transplant community innovating to improve patient outcomes, announce that the New York State Department of Health Clinical Laboratory Evaluation Program (CLEP) has approved the Viracor TRAC™ (Transplant Allograft Rejection Check) donor-derived cell-free DNA test and TruGraf® blood gene expression test, both of which help healthcare providers assess rejection status in kidney transplant recipients.

New yorkUnited statesEurofins viracorEnver akalinBranden morrisPrnewswire eurofins viracorSally maysentLaboratory analysesAlbert einstein college of medicineAmerican medical associationGenomics incYork state department of healthEuronext paris stock exchangePancreas transplant program at montefiore medical centerTransplant genomicsNew york state department